Strategies to reduce transfusion acquired vCJD

Transfusion Medicine

Volumn 21, Issue 1, 2011, Pages 1-6

  Wallis, J P ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Epidemiology; Prion disease; Transfusion; VCJD

Indexed keywords

FRESH FROZEN PLASMA; METHIONINE; PRION PROTEIN; VALINE;

BLOOD DONOR; CODON; COMMUNITY; DIET; DISEASE TRANSMISSION; DONOR; EPIDEMIC; EPIDEMIOLOGY; HEALTH CARE COST; HEALTH SERVICE; HUMAN; KURU; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PLASMA TRANSFUSION; RETROSPECTIVE STUDY; REVIEW; RISK; THROMBOCYTE; UNITED KINGDOM; VARIANT CREUTZFELDT JAKOB DISEASE;

BLOOD DONORS; BLOOD TRANSFUSION; COST-BENEFIT ANALYSIS; CREUTZFELDT-JAKOB SYNDROME; HUMANS;

EID: 78650777567     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2010.01047.x     Document Type: Review

References (22)

1. Alperovitch, A., Zerr, I., Pocchiari, M. et al. (1999) Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet, 353, 1673-1674.
2. Cervenakova, L., Yakovleva, O., McKenzie, C., Kolchinsky, S., McShane, L., Drohan, W.N. & Brown, P. (2003) Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion, 43, 1687-1694.
3. Clewley, J.P., Kelly, C.M., Andrews, N. et al. (2009) Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. British Medical Journal, 338, b1442.
4. Collinge, J., Whitfield, J., McKintosh, E. et al. (2008) A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 363, 3725-3739.
5. Hilton, D.A., Ghani, A.C., Conyers, L. et al. (2004a) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. The Journal of Pathology, 203, 733-739.
6. Hilton, D.A., Sutak, J., Smith, M.E. et al. (2004b) Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. Journal of Clinical Pathology, 57, 300-302.
7. Holada, K., Vostal, J.G., Theisen, P.W., MacAuley, C., Gregori, L. & Rohwer, R.G. (2002) Scrapie infectivity in hamster blood is not associated with platelets. Journal of Virology, 76, 4649-4650.
8. Houston, F., McCutcheon, S., Goldmann, W. et al. (2008) Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood, 112, 4739-4745.
9. Huillard d'Aignaux, J.N., Cousens, S.N., Maccario, J., Costagliola, D., Alpers, M.P., Smith, P.G. & Alperovitch, A. (2002) The incubation period of Kuru. Epidemiology, 13, 402-408.
10. Ironside, J.W., Bishop, M.T., Connolly, K. et al. (2006) Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. British Medical Journal, 332, 1186-1188.
11. Kaski, D., Mead, S., Hyare, H. et al. (2009) Variant CJD in an individual heterozygous for PRNP codon 129. Lancet, 374, 2128.
12. Lefrere, J.J. & Hewitt, P. (2009) From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France. Transfusion, 49, 797-812.
13. Mead, S., Poulter, M., Uphill, J. et al. (2009a) Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurology, 8, 57-66.
14. Mead, S., Whitfield, J., Poulter, M. et al. (2009b) A novel protective prion protein variant that colocalizes with Kuru exposure. The New England Journal of Medicine, 361, 2056-2065.
15. ONS (Office for National Statistics) Internet 24 March 2010. URL (Accessed September 2010).
16. Palmer, M.S., Dryden, A.J., Hughes, J.T. & Collinge, J. (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature, 352, 340-342.
17. Peden, A.H., Head, M.W., Ritchie, D.L., Bell, J.E. & Ironside, J.W. (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet, 364, 527-529.
18. Peden, A., McCardle, L., Head, M.W. et al. (2010) Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia, 16, 296-304.
19. TMER (Transfusion medicine Epidemiology review) (2010). URL (Accessed September 2010).
20. Wadsworth, J.D., Joiner, S., Hill, A.F., Campbell, T.A., Desbruslais, M., Luthert, P.J. & Collinge, J. (2001) Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet, 358, 171-180.
21. Wallis, J.P., Wells, A.W., Matthews, J.N. & Chapman, C.E. (2004) Long-term survival after blood transfusion: a population based study in the North of England. Transfusion, 44, 1025-1032.
22. Ward, H.J. (2009) 17th Annual report 2008; Creutzfeldt-Jakob disease surveillance in the UK. URL (Accessed September 2010).